Webb28 okt. 2011 · 1 Answer. ASP.NET will handle the JSON [de]serialization for you automatically. Change your server-side method to match the type of data you're passing in from the client-side. edit: And as Jon pointed out, your data parameter's property key needs to match the WebMethod's input parameter name (this is case-sensitive even). Webb30 juli 2024 · NSAIDs, including aspirin, do not generally change the course of the disease process in those conditions, where they are used for symptomatic relief. The pharmacology and mechanisms of action of the NSAIDs will be reviewed here. The therapeutic variability and approach to the clinical use of NSAIDs, including their use in combination with other ...
Secondary metabolites and α-glucosidase inhibitory activities of
Webb1 feb. 2024 · CDK4/6 inhibition also decreased the proportion of immunosuppressive CD11c + myeloid cells in tumors, an effect associated with decreased production of IL6, IL10, and IL23. Finally, combination treatment of CDK4/6 inhibitor and PD-1 blockade led to enhanced tumor inhibition which was highly dependent on both CD4 + and CD8 + T … Webb6 apr. 2024 · B7-H6 and PD-L1 belong to the B7 family co-stimulatory molecules fine-tuning the immune response. The present work investigates the clinical effect of B7-H6 … mehta family foundation rahul mehta
Immune Modulatory microRNAs Involved in Tumor Attack and …
Webb18 juni 2024 · B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics … WebbUnlike other B7 family proteins, B7-H6 is not expressed in normal human tissues under steady-state conditions, but it can be induced under inflammatory stress. 1 Accordingly, … Webb18 okt. 2024 · Inhibitoren der Cyclin-abhängigen Kinasen (CDK) 4 und 6 sind indiziert zur Behandlung des Hormonrezeptor (HR)-positiven und humanen epidermalen Wachstumsfaktor-Rezeptor-2 (HER2)-negativen, lokal fortgeschrittenen oder metastasierten Mammakarzinoms in Kombination mit: Aromatasehemmern mehta family group investment